• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗细菌感染mRNA疫苗的研发进展

Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.

作者信息

Khlebnikova Alina, Kirshina Anna, Zakharova Natalia, Ivanov Roman, Reshetnikov Vasiliy

机构信息

Translational Medicine Research Center, Sirius University of Science and Technology, Sochi 354340, Russia.

出版信息

Int J Mol Sci. 2024 Dec 6;25(23):13139. doi: 10.3390/ijms252313139.

DOI:10.3390/ijms252313139
PMID:39684849
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11642352/
Abstract

Bacterial infections have accompanied humanity for centuries. The discovery of the first antibiotics and the subsequent golden era of their discovery temporarily shifted the balance in this confrontation to the side of humans. Nevertheless, the excessive and improper use of antibacterial drugs and the evolution of bacteria has gotten the better of humans again. Therefore, today, the search for new antibacterial drugs or the development of alternative approaches to the prevention and treatment of bacterial infections is relevant and topical again. Vaccination is one of the most effective strategies for the prevention of bacterial infections. The success of new-generation vaccines, such as mRNA vaccines, in the fight against viral infections has prompted many researchers to design mRNA vaccines against bacterial infections. Nevertheless, the biology of bacteria and their interactions with the host's immunity are much more complex compared to viruses. In this review, we discuss structural features and key mechanisms of evasion of an immune response for nine species of bacterial pathogens against which mRNA vaccines have been developed and tested in animals. We focus on the results of experiments involving the application of mRNA vaccines against various bacterial pathogens in animal models and discuss possible options for improving the vaccines' effectiveness. This is one of the first comprehensive reviews of the use of mRNA vaccines against bacterial infections in vivo to improve our knowledge.

摘要

几个世纪以来,细菌感染一直伴随着人类。第一种抗生素的发现以及随后抗生素发现的黄金时代,暂时将这场对抗的平衡转向了人类一方。然而,抗菌药物的过度和不当使用以及细菌的进化再次占据了上风。因此,如今,寻找新的抗菌药物或开发预防和治疗细菌感染的替代方法再次具有相关性和紧迫性。疫苗接种是预防细菌感染最有效的策略之一。新一代疫苗,如mRNA疫苗,在对抗病毒感染方面的成功促使许多研究人员设计针对细菌感染的mRNA疫苗。然而,与病毒相比,细菌的生物学特性及其与宿主免疫系统的相互作用要复杂得多。在这篇综述中,我们讨论了针对其已开发出mRNA疫苗并在动物身上进行测试的9种细菌病原体的结构特征和逃避免疫反应的关键机制。我们重点关注在动物模型中应用mRNA疫苗对抗各种细菌病原体的实验结果,并讨论提高疫苗有效性的可能方案。这是首批关于在体内使用mRNA疫苗对抗细菌感染以增进我们知识的全面综述之一。

相似文献

1
Current Progress in the Development of mRNA Vaccines Against Bacterial Infections.抗细菌感染mRNA疫苗的研发进展
Int J Mol Sci. 2024 Dec 6;25(23):13139. doi: 10.3390/ijms252313139.
2
mRNA vaccine platforms to prevent bacterial infections.mRNA 疫苗平台预防细菌性感染。
Trends Mol Med. 2024 Jun;30(6):524-526. doi: 10.1016/j.molmed.2024.02.013. Epub 2024 Mar 13.
3
Protective immunity induced by a novel P1 adhesin C-terminal anchored mRNA vaccine against infection in BALB/c mice.一种新型P1黏附素C末端锚定mRNA疫苗诱导的针对BALB/c小鼠感染的保护性免疫。
Microbiol Spectr. 2025 Mar 4;13(3):e0214024. doi: 10.1128/spectrum.02140-24. Epub 2025 Jan 20.
4
Current innovations in mRNA vaccines for targeting multidrug-resistant ESKAPE pathogens.用于靶向多重耐药性ESKAPE病原体的mRNA疫苗的当前创新成果。
Biotechnol Adv. 2025 Mar-Apr;79:108492. doi: 10.1016/j.biotechadv.2024.108492. Epub 2024 Dec 3.
5
A review on the development of bacterial multi-epitope recombinant protein vaccines via reverse vaccinology.基于反向疫苗学的细菌多表位重组蛋白疫苗发展综述
Int J Biol Macromol. 2024 Dec;282(Pt 5):136827. doi: 10.1016/j.ijbiomac.2024.136827. Epub 2024 Oct 28.
6
Exploring computational approaches to design mRNA Vaccine against vaccinia and Mpox viruses.探索针对天花和猴痘病毒设计 mRNA 疫苗的计算方法。
Immun Inflamm Dis. 2024 Aug;12(8):e1360. doi: 10.1002/iid3.1360.
7
Computational biology and artificial intelligence in mRNA vaccine design for cancer immunotherapy.用于癌症免疫治疗的mRNA疫苗设计中的计算生物学与人工智能
Front Cell Infect Microbiol. 2025 Jan 20;14:1501010. doi: 10.3389/fcimb.2024.1501010. eCollection 2024.
8
Advancement in the development of mRNA-based vaccines for respiratory viruses.mRNA 疫苗在呼吸道病毒研发中的进展。
Immunology. 2024 Nov;173(3):481-496. doi: 10.1111/imm.13844. Epub 2024 Aug 19.
9
mRNA-LNP vaccines combined with tPA signal sequence elicit strong protective immunity against .与组织型纤溶酶原激活剂(tPA)信号序列结合的信使核糖核酸-脂质纳米颗粒(mRNA-LNP)疫苗可引发针对……的强大保护性免疫。
mSphere. 2025 Jan 28;10(1):e0077524. doi: 10.1128/msphere.00775-24. Epub 2024 Dec 31.
10
A Comparison Between Recombinant GAPDH Proteins and GAPDH Encoding mRNA Conjugated to Lipids as Cross-Reactive Vaccines for , and .重组 GAPDH 蛋白与脂质偶联的 GAPDH 编码 mRNA 作为 和 的交叉反应性疫苗的比较。
Front Immunol. 2021 Apr 19;12:632304. doi: 10.3389/fimmu.2021.632304. eCollection 2021.

引用本文的文献

1
Harnessing the Potential of mRNA Vaccines Against Infectious Diseases.利用mRNA疫苗对抗传染病的潜力。
Microb Biotechnol. 2025 Aug;18(8):e70212. doi: 10.1111/1751-7915.70212.
2
Mini-review on the therapeutic vaccines targeting chronic infectious diseases: Evaluation system of therapeutic vaccines targeting HPV and EBV-related cancers.针对慢性传染病的治疗性疫苗综述:人乳头瘤病毒和爱泼斯坦-巴尔病毒相关癌症治疗性疫苗的评估体系
Hum Vaccin Immunother. 2025 Dec;21(1):2457187. doi: 10.1080/21645515.2025.2457187. Epub 2025 Feb 16.

本文引用的文献

1
A Cap-Optimized mRNA Encoding Multiepitope Antigen ESAT6 Induces Robust Cellular and Humoral Immune Responses Against .一种编码多表位抗原ESAT6的帽优化mRNA可诱导针对……的强大细胞免疫和体液免疫反应。
Vaccines (Basel). 2024 Nov 9;12(11):1267. doi: 10.3390/vaccines12111267.
2
Composition of lipid nanoparticles for targeted delivery: application to mRNA therapeutics.用于靶向递送的脂质纳米颗粒的组成:在mRNA治疗中的应用。
Front Pharmacol. 2024 Oct 23;15:1466337. doi: 10.3389/fphar.2024.1466337. eCollection 2024.
3
Site-Specific Conjugation of Cell Wall Polyrhamnose to Protein SpyAD Envisioning a Safe Universal Group A Streptococcal Vaccine.细胞壁多聚鼠李糖与蛋白SpyAD的位点特异性缀合:设想一种安全的通用A群链球菌疫苗
Infect Microbes Dis. 2021 Jun;3(2):87-100. doi: 10.1097/im9.0000000000000044. Epub 2020 Dec 29.
4
DNA and RNA vaccines against tuberculosis: a scoping review of human and animal studies.DNA 和 RNA 结核病疫苗:人体和动物研究的范围综述。
Front Immunol. 2024 Oct 3;15:1457327. doi: 10.3389/fimmu.2024.1457327. eCollection 2024.
5
Autophagy: the misty lands of infection.自噬:感染的神秘领域。
Front Cell Infect Microbiol. 2024 Sep 6;14:1442995. doi: 10.3389/fcimb.2024.1442995. eCollection 2024.
6
A novel mRNA multi-epitope vaccine of Acinetobacter baumannii based on multi-target protein design in immunoinformatic approach.基于免疫信息学方法的多靶标蛋白设计的鲍曼不动杆菌新型 mRNA 多表位疫苗。
BMC Genomics. 2024 Aug 19;25(1):791. doi: 10.1186/s12864-024-10691-7.
7
Immunogenicity of a 30-valent M protein mRNA group A Streptococcus vaccine.30 价 M 蛋白 mRNA 型 A 群链球菌疫苗的免疫原性。
Vaccine. 2024 Sep 17;42(22):126205. doi: 10.1016/j.vaccine.2024.126205. Epub 2024 Aug 13.
8
Structural Assessment of Major Outer Membrane Protein (MOMP)-Derived Vaccine Antigens and Immunological Profiling in Mice with Different Genetic Backgrounds.不同遗传背景小鼠中主要外膜蛋白(MOMP)衍生疫苗抗原的结构评估及免疫分析
Vaccines (Basel). 2024 Jul 18;12(7):789. doi: 10.3390/vaccines12070789.
9
Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial.在美国健康成年人中,原发性免疫接种后 18 个月加强接种 VLA15 莱姆疏螺旋体疫苗候选物的免疫原性和安全性:一项随机、对照、2 期试验加强期的结果。
Lancet Infect Dis. 2024 Nov;24(11):1275-1286. doi: 10.1016/S1473-3099(24)00372-4. Epub 2024 Jul 16.
10
Immunization with an mRNA DTP vaccine protects against pertussis in rats.接种 mRNA DTP 疫苗可预防大鼠百日咳。
Infect Immun. 2024 Aug 13;92(8):e0052023. doi: 10.1128/iai.00520-23. Epub 2024 Jul 17.